Inter Pharma PCL (BKK: IP)

Inter Pharma PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	218.2	412.39	776.42	173.87	152.33	342.65
Short-Term Investments	1.11	0.86	0.83	0.8	0.77	0.19
Cash & Short-Term Investments	219.32	413.25	777.25	174.67	153.09	342.84
Cash Growth	-55.31%	-46.83%	344.99%	14.09%	-55.35%	950.73%
Accounts Receivable	277.51	337.32	340.3	258.11	124.38	102.67
Other Receivables	106.86	87.74	51.89	34.08	31.49	1.9
Receivables	384.36	425.06	392.2	292.25	155.93	104.63
Inventory	368.24	351.82	332.98	192	107.65	51.43
Prepaid Expenses	-	-	-	-	-	5.66
Other Current Assets	9.63	12.72	12.78	7.7	0.61	0.5
Total Current Assets	981.54	1,203	1,515	666.61	417.28	505.05
Property, Plant & Equipment	1,094	929.27	880.77	457.32	255.39	9.67
Long-Term Investments	135.42	43.37	9.35	10.12	-	4.61
Goodwill	477.85	477.85	477.85	22.16	22.16	-
Other Intangible Assets	205.01	197.36	167.79	55.1	48.58	1.28
Long-Term Deferred Tax Assets	17.97	15.91	9.81	8.98	3.38	3.26
Other Long-Term Assets	74.3	85.75	29.52	106.76	9.5	1.89
Total Assets	2,986	2,952	3,090	1,327	756.33	525.88
Accounts Payable	185.06	200.52	193.79	69.65	58.49	17.14
Accrued Expenses	47.07	47.06	34.74	15.92	11.69	7.69
Short-Term Debt	67.78	46.34	48.73	131.01	11.01	9.23
Current Portion of Long-Term Debt	55.21	54.43	72.51	35.62	15.53	-
Current Portion of Leases	30.23	38.89	30.46	0.57	0.64	-
Current Income Taxes Payable	4.22	4.11	25.18	14.8	8.4	5.35
Other Current Liabilities	93.21	87.39	92.55	68.06	54.58	16.82
Total Current Liabilities	482.78	478.75	497.95	335.63	160.35	56.23
Long-Term Debt	181.03	205.46	319.61	187.06	90.91	-
Long-Term Leases	66.23	54.83	67.69	1.9	2.47	-
Long-Term Deferred Tax Liabilities	59.45	59.21	55.33	3.53	7.62	-
Other Long-Term Liabilities	17.89	3.66	2.14	-	-	-
Total Liabilities	847.31	834.65	973.86	543.54	269.89	60.13
Common Stock	302.67	186.26	186.26	149.01	103	103
Additional Paid-In Capital	1,498	1,498	1,498	492.09	304.98	304.98
Retained Earnings	118.9	225.25	238.26	116.85	58.16	44.02
Comprehensive Income & Other	3.7	3.7	3.7	3.7	3.7	3.7
Total Common Equity	1,923	1,913	1,926	761.64	469.85	455.71
Minority Interest	215.28	204.53	190.25	21.86	16.59	10.03
Shareholders' Equity	2,139	2,118	2,116	783.5	486.44	465.74
Total Liabilities & Equity	2,986	2,952	3,090	1,327	756.33	525.88
Total Debt	400.49	399.95	539	356.17	120.57	9.23
Net Cash (Debt)	-181.17	13.3	238.25	-181.5	32.53	333.61
Net Cash Growth	-	-94.42%	-	-	-90.25%	1496.82%
Net Cash Per Share	-0.30	0.02	0.45	-0.38	0.07	0.94
Filing Date Shares Outstanding	605.34	605.35	605.35	484.27	468.65	468.65
Total Common Shares Outstanding	605.34	605.35	605.35	484.27	468.65	468.65
Working Capital	498.77	724.1	1,017	330.98	256.93	448.82
Book Value Per Share	3.18	3.16	3.18	1.57	1.00	0.97
Tangible Book Value	1,240	1,238	1,281	684.38	399.11	454.43
Tangible Book Value Per Share	2.05	2.05	2.12	1.41	0.85	0.97
Land	-	327.63	327.63	183.25	117.3	-
Buildings	-	430.08	404.55	177.13	66.64	0.52
Machinery	-	346.66	310.51	148.3	105.7	13.49
Construction In Progress	-	57.17	15.97	0.33	1.1	-

Source: S&P Capital IQ. Standard template. Financial Sources.